(Q34092228)

31 July 2017

title

Emerging Issues in Nosocomial Fungal Infections (English)

1 reference

31 July 2017

Toscano CM

1

1 reference

31 July 2017

Jarvis WR

series ordinal

2

1 reference

31 July 2017

publication date

1 October 1999

1 reference

Current infectious disease reports

31 July 2017

published in

1 reference

31 July 2017

volume

1

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

347-361

1 reference

Importance of Candida species other than C. albicans as pathogens in oncology patients

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Candidemia in a pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Acremonium kiliense endophthalmitis that occurred after cataract extraction in an ambulatory surgical center and was traced to an environmental reservoir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Correlation between in vitro and in vivo activity of antifungal agents against Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Is antifungal susceptibility testing useful in guiding fluconazole therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Problems and controversies in the management of hematogenous candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Role of azoles in antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0041-3

Risk factors for candidemia in patients with acute lymphocytic leukemia

21 January 2018

1 reference

12 December 2020

Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study

1 reference

12 December 2020

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

1 reference

12 December 2020

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

12 December 2020

Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals

1 reference

12 December 2020

The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

1 reference

12 December 2020

Risk factors for candidemia in a children's hospital

1 reference

12 December 2020

Rapid identification of Candida species in blood cultures by a clinically useful PCR method

1 reference

12 December 2020

The epidemiology of hematogenous candidiasis caused by different Candida species

1 reference

12 December 2020

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

12 December 2020

Nosocomial Candida glabrata colonization: an epidemiologic study.

1 reference

12 December 2020

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.

1 reference

12 December 2020

Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team.

1 reference

12 December 2020

Epidemiology of nosocomial acquisition of Candida lusitaniae

1 reference

12 December 2020

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections

1 reference

12 December 2020

Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis

1 reference

12 December 2020

An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs.

1 reference

12 December 2020

Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis

1 reference

12 December 2020

Nosocomial acquisition of Candida parapsilosis: an epidemiologic study

1 reference

12 December 2020

Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.

1 reference

12 December 2020

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Par

1 reference

12 December 2020

A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia

1 reference

12 December 2020

Hospital-acquired candidemia. The attributable mortality and excess length of stay

1 reference

12 December 2020

Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study

1 reference

12 December 2020

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

1 reference

12 December 2020

Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis

1 reference

12 December 2020

Association of fungal colonization and invasive disease in very low birth weight infants.

1 reference

12 December 2020

Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis

1 reference

12 December 2020

Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study

1 reference

12 December 2020

Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients

1 reference

12 December 2020

Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection

1 reference

12 December 2020

Candida parapsilosis Fungemia Associated with Implantable and Semi-Implantable Central Venous Catheters and the Hands of Healthcare Workers

1 reference

12 December 2020

Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.

1 reference

12 December 2020

Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia.

1 reference

12 December 2020

Comparison of three methods for recovery of yeasts from hands of health-care workers.

1 reference

12 December 2020

Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol

1 reference

12 December 2020

Predictors of adverse outcome in cancer patients with candidemia

1 reference

12 December 2020

Antifungal prophylaxis during neutropenia and immunodeficiency

1 reference

12 December 2020

Composition and density of microflora in the subungual space of the hand

1 reference

12 December 2020

Failure of amphotericin B spray to prevent aspergillosis in granulocytopenic patients

1 reference

12 December 2020

Fungal infections in cancer patients: an international autopsy survey.

1 reference

12 December 2020

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

1 reference

12 December 2020

Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients

1 reference

12 December 2020

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

12 December 2020

Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients. Bone Marrow Transplantation Team

1 reference

12 December 2020

Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors

1 reference

12 December 2020

Rhizopus microsporus in wooden tongue depressors: a major threat or minor inconvenience?

1 reference

12 December 2020

Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit

1 reference

12 December 2020

Risk factors for hospital-acquired candidemia. A matched case-control study

1 reference

12 December 2020

Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation

1 reference

12 December 2020

Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group

1 reference

12 December 2020

High frequency of yeast carriage on hands of hospital personnel.

1 reference

12 December 2020

Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia

1 reference

12 December 2020

Nosocomial candidemia: risk factors and attributable mortality

1 reference

12 December 2020

Assessment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease

1 reference

12 December 2020

Candida colonization and subsequent infections in critically ill surgical patients

1 reference

12 December 2020

Use of macrophage colony-stimulating factor in the treatment of fungal infections

1 reference

12 December 2020

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

1 reference

12 December 2020

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

12 December 2020

Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study

1 reference

12 December 2020

The prophylactic use of low-dose amphotericin B in bone marrow transplant patients

1 reference

12 December 2020

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species

1 reference

12 December 2020

A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia

1 reference

12 December 2020

Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients

1 reference

12 December 2020

Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia

1 reference

12 December 2020

Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies

1 reference

12 December 2020

Rapid identification of Candida species with species-specific DNA probes

1 reference

12 December 2020

Strain variation among and antifungal susceptibilities of isolates of Candida krusei

1 reference

12 December 2020

Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia

1 reference

12 December 2020

Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients

1 reference

12 December 2020

Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis

1 reference

12 December 2020

Amphotericin B colloidal dispersion for treatment of candidemia in immunocompromised patients.

1 reference

12 December 2020

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

12 December 2020

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

12 December 2020

Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation

1 reference

12 December 2020

National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System

1 reference

12 December 2020

Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection

1 reference

12 December 2020

Single-source outbreak of Candida tropicalis complicating coronary bypass surgery

1 reference

12 December 2020

Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia

1 reference

12 December 2020

Risk factors for nosocomial candidemia: a case-control study in adults without leukemia

1 reference

12 December 2020

Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion

1 reference

12 December 2020

Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group

1 reference

12 December 2020

National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

1 reference

12 December 2020

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group

1 reference

12 December 2020

Prophylactic use of fluconazole in neutropenic cancer patients

1 reference

12 December 2020

Successful program to prevent aspergillus infections in children undergoing marrow transplantation: use of nasal amphotericin

1 reference

12 December 2020

Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis

1 reference

12 December 2020

Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses.

1 reference

12 December 2020

Lipid formulations of amphotericin B: clinical efficacy and toxicities

1 reference

12 December 2020

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

1 reference

12 December 2020

10.1007/S11908-999-0041-3

Identifiers

DOI

1 reference

31 July 2017

1 reference